Your browser doesn't support javascript.
loading
Clinical outcomes of doxorubicin-eluting CalliSpheres® beads-transarterial chemoembolization for unresectable or recurrent esophageal carcinoma.
Bi, Yonghua; Shi, Xiaonan; Ren, Jianzhuang; Yi, Mengfei; Han, Xinwei; Song, Min.
  • Bi Y; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, No.1, East Jian She Road, Zhengzhou, 450052, China.
  • Shi X; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Ren J; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, No.1, East Jian She Road, Zhengzhou, 450052, China.
  • Yi M; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, No.1, East Jian She Road, Zhengzhou, 450052, China.
  • Han X; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, No.1, East Jian She Road, Zhengzhou, 450052, China. dreamweaver08@126.com.
  • Song M; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
BMC Gastroenterol ; 21(1): 231, 2021 May 21.
Article en En | MEDLINE | ID: mdl-34020608

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Quimioembolización Terapéutica / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Observational_studies Límite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Quimioembolización Terapéutica / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Observational_studies Límite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article